CellWell record HH-76648
Luspatercept in Transfusion-Dependent Thalassemia With Red Blood Cell Antibodies: A Case Series
Nattiya Teawtrakul
2026
In plain language
In seven adults with transfusion-dependent thalassemia and red cell antibodies, six cut transfusion needs during weeks 13 to 24 by a median of three units per 12 weeks on luspatercept.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-76648
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.